Abstract
Patients with ESKD undergoing hemodialysis are at high risk for cardiovascular events, which have been associated with abnormal phosphate homeostasis. Hyperphosphatemia and elevated serum fibroblast growth factor 23 (FGF23) cause vascular calcifications and left ventricular hypertrophy, respectively
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Clinical journal of the American Society of Nephrology : CJASN
Paper Title
Journal
Date
